4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001193125-26-418094
Chief Financial Officer sold 17,717 shares at an average $18.59 ($329,322)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Catinazzo Thomas · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-06 | Sale : show line 1 in the form 10b5-1 | −17,511 | $18.58 | $325,354 | 105,340 | D |
| 2026-10-06 | Sale : show line 2 in the form 10b5-1 | −206 | $19.26 | $3,968 | 105,134 | D |
| Open-market sales · 17,717 sh · avg $18.59 · $329,322 | ||||||
Loading xslF345X06/ownership.xml…